Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant Acinetobacter baumannii

Abstract Background: Whole-genome sequencing (WGS) shotgun metagenomics (metagenomics) attempts to sequence the entire genetic content straight from the sample. Diagnostic advantages lie in the ability to detect unsuspected, uncultivatable, or very slow-growing organisms. Objective: To evaluate...

Full description

Bibliographic Details
Main Authors: Thomas M. Elliott, Patrick N. Harris, Leah W. Roberts, Michelle Doidge, Trish Hurst, Krispin Hajkowicz, Brian Forde, David L. Paterson, Louisa G. Gordon
Format: Article
Language:English
Published: Cambridge University Press 2021-01-01
Series:Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:https://www.cambridge.org/core/product/identifier/S2732494X21002333/type/journal_article
_version_ 1811157244608249856
author Thomas M. Elliott
Patrick N. Harris
Leah W. Roberts
Michelle Doidge
Trish Hurst
Krispin Hajkowicz
Brian Forde
David L. Paterson
Louisa G. Gordon
author_facet Thomas M. Elliott
Patrick N. Harris
Leah W. Roberts
Michelle Doidge
Trish Hurst
Krispin Hajkowicz
Brian Forde
David L. Paterson
Louisa G. Gordon
author_sort Thomas M. Elliott
collection DOAJ
description Abstract Background: Whole-genome sequencing (WGS) shotgun metagenomics (metagenomics) attempts to sequence the entire genetic content straight from the sample. Diagnostic advantages lie in the ability to detect unsuspected, uncultivatable, or very slow-growing organisms. Objective: To evaluate the clinical and economic effects of using WGS and metagenomics for outbreak management in a large metropolitan hospital. Design: Cost-effectiveness study. Setting: Intensive care unit and burn unit of large metropolitan hospital. Patients: Simulated intensive care unit and burn unit patients. Methods: We built a complex simulation model to estimate pathogen transmission, associated hospital costs, and quality-adjusted life years (QALYs) during a 32-month outbreak of carbapenem-resistant Acinetobacter baumannii (CRAB). Model parameters were determined using microbiology surveillance data, genome sequencing results, hospital admission databases, and local clinical knowledge. The model was calibrated to the actual pathogen spread within the intensive care unit and burn unit (scenario 1) and compared with early use of WGS (scenario 2) and early use of WGS and metagenomics (scenario 3) to determine their respective cost-effectiveness. Sensitivity analyses were performed to address model uncertainty. Results: On average compared with scenario 1, scenario 2 resulted in 14 fewer patients with CRAB, 59 additional QALYs, and $75,099 cost savings. Scenario 3, compared with scenario 1, resulted in 18 fewer patients with CRAB, 74 additional QALYs, and $93,822 in hospital cost savings. The likelihoods that scenario 2 and scenario 3 were cost-effective were 57% and 60%, respectively. Conclusions: The use of WGS and metagenomics in infection control processes were predicted to produce favorable economic and clinical outcomes.
first_indexed 2024-04-10T05:03:57Z
format Article
id doaj.art-a534bbbda1f648a4adbf02e718f87ad9
institution Directory Open Access Journal
issn 2732-494X
language English
last_indexed 2024-04-10T05:03:57Z
publishDate 2021-01-01
publisher Cambridge University Press
record_format Article
series Antimicrobial Stewardship & Healthcare Epidemiology
spelling doaj.art-a534bbbda1f648a4adbf02e718f87ad92023-03-09T12:27:47ZengCambridge University PressAntimicrobial Stewardship & Healthcare Epidemiology2732-494X2021-01-01110.1017/ash.2021.233Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant Acinetobacter baumanniiThomas M. Elliott0https://orcid.org/0000-0002-7702-7688Patrick N. Harris1https://orcid.org/0000-0002-2895-0345Leah W. Roberts2https://orcid.org/0000-0002-1024-0564Michelle Doidge3Trish Hurst4Krispin Hajkowicz5Brian Forde6https://orcid.org/0000-0002-2264-4785David L. Paterson7Louisa G. Gordon8https://orcid.org/0000-0002-3159-4249QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, AustraliaThe University of Queensland, Centre for Clinical Research, Herston, Brisbane, Queensland, Australia Central Microbiology, Pathology Queensland, Royal Brisbane and Women’s Hospital, Herston, Brisbane, Queensland, AustraliaSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, United KingdomInfectious Diseases Unit, Royal Brisbane and Womens’ Hospital, Herston, Brisbane, Queensland, AustraliaInfectious Diseases Unit, Royal Brisbane and Womens’ Hospital, Herston, Brisbane, Queensland, AustraliaCentral Microbiology, Pathology Queensland, Royal Brisbane and Women’s Hospital, Herston, Brisbane, Queensland, Australia Infectious Diseases Unit, Royal Brisbane and Womens’ Hospital, Herston, Brisbane, Queensland, AustraliaThe University of Queensland, Centre for Clinical Research, Herston, Brisbane, Queensland, Australia School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, AustraliaThe University of Queensland, Centre for Clinical Research, Herston, Brisbane, Queensland, AustraliaQIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia The University of Queensland, School of Public Health, Brisbane, Queensland, Australia Queensland University of Technology, School of Nursing, Kelvin Grove, Brisbane, Queensland, Australia Abstract Background: Whole-genome sequencing (WGS) shotgun metagenomics (metagenomics) attempts to sequence the entire genetic content straight from the sample. Diagnostic advantages lie in the ability to detect unsuspected, uncultivatable, or very slow-growing organisms. Objective: To evaluate the clinical and economic effects of using WGS and metagenomics for outbreak management in a large metropolitan hospital. Design: Cost-effectiveness study. Setting: Intensive care unit and burn unit of large metropolitan hospital. Patients: Simulated intensive care unit and burn unit patients. Methods: We built a complex simulation model to estimate pathogen transmission, associated hospital costs, and quality-adjusted life years (QALYs) during a 32-month outbreak of carbapenem-resistant Acinetobacter baumannii (CRAB). Model parameters were determined using microbiology surveillance data, genome sequencing results, hospital admission databases, and local clinical knowledge. The model was calibrated to the actual pathogen spread within the intensive care unit and burn unit (scenario 1) and compared with early use of WGS (scenario 2) and early use of WGS and metagenomics (scenario 3) to determine their respective cost-effectiveness. Sensitivity analyses were performed to address model uncertainty. Results: On average compared with scenario 1, scenario 2 resulted in 14 fewer patients with CRAB, 59 additional QALYs, and $75,099 cost savings. Scenario 3, compared with scenario 1, resulted in 18 fewer patients with CRAB, 74 additional QALYs, and $93,822 in hospital cost savings. The likelihoods that scenario 2 and scenario 3 were cost-effective were 57% and 60%, respectively. Conclusions: The use of WGS and metagenomics in infection control processes were predicted to produce favorable economic and clinical outcomes. https://www.cambridge.org/core/product/identifier/S2732494X21002333/type/journal_article
spellingShingle Thomas M. Elliott
Patrick N. Harris
Leah W. Roberts
Michelle Doidge
Trish Hurst
Krispin Hajkowicz
Brian Forde
David L. Paterson
Louisa G. Gordon
Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant Acinetobacter baumannii
Antimicrobial Stewardship & Healthcare Epidemiology
title Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant Acinetobacter baumannii
title_full Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant Acinetobacter baumannii
title_fullStr Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant Acinetobacter baumannii
title_full_unstemmed Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant Acinetobacter baumannii
title_short Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant Acinetobacter baumannii
title_sort cost effectiveness analysis of whole genome sequencing during an outbreak of carbapenem resistant acinetobacter baumannii
url https://www.cambridge.org/core/product/identifier/S2732494X21002333/type/journal_article
work_keys_str_mv AT thomasmelliott costeffectivenessanalysisofwholegenomesequencingduringanoutbreakofcarbapenemresistantacinetobacterbaumannii
AT patricknharris costeffectivenessanalysisofwholegenomesequencingduringanoutbreakofcarbapenemresistantacinetobacterbaumannii
AT leahwroberts costeffectivenessanalysisofwholegenomesequencingduringanoutbreakofcarbapenemresistantacinetobacterbaumannii
AT michelledoidge costeffectivenessanalysisofwholegenomesequencingduringanoutbreakofcarbapenemresistantacinetobacterbaumannii
AT trishhurst costeffectivenessanalysisofwholegenomesequencingduringanoutbreakofcarbapenemresistantacinetobacterbaumannii
AT krispinhajkowicz costeffectivenessanalysisofwholegenomesequencingduringanoutbreakofcarbapenemresistantacinetobacterbaumannii
AT brianforde costeffectivenessanalysisofwholegenomesequencingduringanoutbreakofcarbapenemresistantacinetobacterbaumannii
AT davidlpaterson costeffectivenessanalysisofwholegenomesequencingduringanoutbreakofcarbapenemresistantacinetobacterbaumannii
AT louisaggordon costeffectivenessanalysisofwholegenomesequencingduringanoutbreakofcarbapenemresistantacinetobacterbaumannii